| striated muscle contraction | GO:0006941 | 45 | 0.628 | Human |
| muscle cell development | GO:0055001 | 133 | 0.619 | Human |
| muscle system process | GO:0003012 | 141 | 0.556 | Human |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.549 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.544 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.498 | Human |
| regulation of system process | GO:0044057 | 200 | 0.487 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.482 | Human |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.480 | |
| cation transport | GO:0006812 | 399 | 0.471 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.448 | Human |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.426 | |
| heart morphogenesis | GO:0003007 | 178 | 0.407 | Human |
| striated muscle tissue development | GO:0014706 | 293 | 0.405 | Human |
| muscle adaptation | GO:0043500 | 39 | 0.383 | Human |
| calcium ion transport | GO:0006816 | 159 | 0.380 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.373 | |
| cellular homeostasis | GO:0019725 | 240 | 0.371 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.365 | Human |
| cation homeostasis | GO:0055080 | 212 | 0.359 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.354 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.327 | |
| transmembrane transport | GO:0055085 | 412 | 0.325 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.321 | Human |
| muscle contraction | GO:0006936 | 101 | 0.320 | Human |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.316 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.313 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.312 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.312 | |
| skeletal muscle adaptation | GO:0043501 | 16 | 0.310 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.308 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.308 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.303 | |
| regulation of ion transport | GO:0043269 | 215 | 0.302 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.300 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.287 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.280 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.275 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.273 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.272 | Human |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.271 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.254 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.253 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.251 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.249 | Human |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.246 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.245 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.242 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.242 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.237 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.236 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.234 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.233 | |
| regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | GO:0010881 | 7 | 0.231 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.228 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.226 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.226 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.224 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.215 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.213 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.211 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.210 | |
| muscle tissue development | GO:0060537 | 308 | 0.208 | Human |
| regulation of skeletal muscle adaptation | GO:0014733 | 12 | 0.207 | |
| transition between fast and slow fiber | GO:0014883 | 9 | 0.207 | |
| muscle filament sliding | GO:0030049 | 1 | 0.205 | |
| heart contraction | GO:0060047 | 93 | 0.202 | Human |
| nucleotide catabolic process | GO:0009166 | 217 | 0.197 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.195 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.194 | |
| endoplasmic reticulum to cytosol transport | GO:1903513 | 12 | 0.194 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.189 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.189 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.188 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.185 | |
| locomotory behavior | GO:0007626 | 195 | 0.184 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.183 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.177 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.174 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.173 | |
| synaptic transmission | GO:0007268 | 329 | 0.173 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.171 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.171 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.169 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.169 | |
| regulation of atp catabolic process | GO:1903289 | 9 | 0.167 | |
| regulation of atp metabolic process | GO:1903578 | 17 | 0.164 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.164 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.164 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.160 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.159 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.156 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.155 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.154 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.152 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.149 | |
| cellular modified amino acid biosynthetic process | GO:0042398 | 12 | 0.149 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.149 | |
| calcium ion transport from endoplasmic reticulum to cytosol | GO:1903514 | 12 | 0.146 | |
| maintenance of location | GO:0051235 | 89 | 0.144 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.143 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.143 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.143 | |
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0010880 | 10 | 0.142 | |
| blood circulation | GO:0008015 | 195 | 0.140 | Human |
| organophosphate catabolic process | GO:0046434 | 232 | 0.139 | |
| organelle assembly | GO:0070925 | 177 | 0.138 | Human |
| fatty acid metabolic process | GO:0006631 | 121 | 0.135 | |
| striated muscle cell development | GO:0055002 | 125 | 0.134 | Human |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.131 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.131 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.127 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.127 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.123 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.123 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.120 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.120 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.120 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.119 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.119 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.117 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.113 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.112 | |
| regulation of striated muscle contraction | GO:0006942 | 25 | 0.112 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.109 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.109 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.109 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.108 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.107 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.105 | |
| oxidation reduction process | GO:0055114 | 342 | 0.103 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.103 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.101 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.100 | |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0014808 | 12 | 0.097 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.096 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.093 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.093 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.092 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.091 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.091 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.090 | |
| regulation of tube size | GO:0035150 | 57 | 0.089 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.088 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.088 | |
| myosin filament organization | GO:0031033 | 3 | 0.086 | Human |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.086 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.085 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.085 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.085 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.084 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.084 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.084 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.082 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.082 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.081 | |
| myosin filament assembly | GO:0031034 | 2 | 0.081 | Human |
| lipid localization | GO:0010876 | 126 | 0.080 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.080 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.078 | |
| regulation of cell size | GO:0008361 | 72 | 0.077 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.077 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.077 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.077 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.076 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.076 | |
| regulation of cardiac muscle contraction by calcium ion signaling | GO:0010882 | 9 | 0.076 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.075 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.075 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.075 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.074 | |
| membrane organization | GO:0061024 | 245 | 0.073 | |
| negative regulation of potassium ion transmembrane transporter activity | GO:1901017 | 3 | 0.073 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.073 | Human |
| regulation of heart contraction | GO:0008016 | 77 | 0.073 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.072 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.072 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.071 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.070 | |
| circulatory system process | GO:0003013 | 197 | 0.070 | Human |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.069 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.068 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.067 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.066 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.066 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.066 | |
| potassium ion transport | GO:0006813 | 52 | 0.065 | |
| myofibril assembly | GO:0030239 | 34 | 0.065 | Human |
| t cell differentiation | GO:0030217 | 174 | 0.065 | |
| positive regulation of muscle contraction | GO:0045933 | 10 | 0.064 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.064 | |
| atp metabolic process | GO:0046034 | 75 | 0.064 | |
| fat cell differentiation | GO:0045444 | 160 | 0.064 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.064 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.063 | |
| actin filament based movement | GO:0030048 | 23 | 0.062 | |
| protein ubiquitination | GO:0016567 | 171 | 0.061 | |
| cardiac chamber development | GO:0003205 | 108 | 0.061 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.061 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.060 | Human |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.060 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.060 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.059 | |
| developmental cell growth | GO:0048588 | 84 | 0.059 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.058 | Human |
| neurotransmitter secretion | GO:0007269 | 62 | 0.058 | |
| protein localization to membrane | GO:0072657 | 108 | 0.058 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.058 | |
| anion transport | GO:0006820 | 177 | 0.057 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.057 | |
| regionalization | GO:0003002 | 337 | 0.057 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.055 | |
| relaxation of muscle | GO:0090075 | 18 | 0.055 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.055 | |
| cell growth | GO:0016049 | 130 | 0.055 | |
| regulation of defense response | GO:0031347 | 233 | 0.055 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.054 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.053 | |
| positive regulation of potassium ion transport | GO:0043268 | 3 | 0.053 | |
| response to inorganic substance | GO:0010035 | 96 | 0.052 | |
| cytokine production | GO:0001816 | 319 | 0.052 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.052 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.052 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.052 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.052 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.050 | |
| myotube differentiation | GO:0014902 | 105 | 0.050 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.050 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.050 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.049 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.049 | |
| endomembrane system organization | GO:0010256 | 147 | 0.049 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.049 | |
| regulation of macrophage activation | GO:0043030 | 17 | 0.048 | |
| learning or memory | GO:0007611 | 148 | 0.048 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.048 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.048 | |
| atp catabolic process | GO:0006200 | 55 | 0.047 | |
| amine metabolic process | GO:0009308 | 45 | 0.047 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.046 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.046 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.046 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.046 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.046 | |
| positive regulation of potassium ion transmembrane transport | GO:1901381 | 3 | 0.045 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.045 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.045 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.045 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.045 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.045 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.045 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.045 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.044 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.044 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.044 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.043 | |
| interleukin 8 production | GO:0032637 | 4 | 0.043 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.043 | |
| maintenance of cell number | GO:0098727 | 3 | 0.043 | |
| heart process | GO:0003015 | 94 | 0.043 | Human |
| axonogenesis | GO:0007409 | 274 | 0.042 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.042 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.042 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.042 | Human |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.042 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.042 | |
| innate immune response | GO:0045087 | 157 | 0.041 | |
| regulation of synaptic activity | GO:0060025 | 1 | 0.041 | |
| telencephalon development | GO:0021537 | 186 | 0.041 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.041 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.041 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.041 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.041 | Human |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.041 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.040 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.040 | |
| negative regulation of potassium ion transport | GO:0043267 | 7 | 0.040 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.039 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.039 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.039 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.039 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.038 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.038 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.038 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.038 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.038 | |
| histone acetylation | GO:0016573 | 41 | 0.038 | |
| cerebellum development | GO:0021549 | 77 | 0.038 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.037 | |
| response to muscle inactivity | GO:0014870 | 4 | 0.037 | |
| positive regulation of cardiac muscle contraction | GO:0060452 | 2 | 0.037 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.037 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.037 | |
| gtp metabolic process | GO:0046039 | 144 | 0.037 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.037 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.036 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.036 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.036 | |
| cognition | GO:0050890 | 149 | 0.036 | |
| metencephalon development | GO:0022037 | 89 | 0.036 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.036 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.036 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.036 | |
| actin myosin filament sliding | GO:0033275 | 1 | 0.036 | |
| microglial cell activation | GO:0001774 | 3 | 0.035 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.035 | |
| mitochondrion organization | GO:0007005 | 134 | 0.035 | |
| positive regulation of high voltage gated calcium channel activity | GO:1901843 | 1 | 0.035 | |
| cellular amino acid biosynthetic process | GO:0008652 | 22 | 0.035 | |
| microtubule based process | GO:0007017 | 236 | 0.035 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.035 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.035 | |
| myotube cell development | GO:0014904 | 60 | 0.035 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.035 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.035 | |
| neuron projection extension | GO:1990138 | 64 | 0.035 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.035 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.034 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.034 | |
| organelle fission | GO:0048285 | 170 | 0.034 | |
| skeletal muscle thin filament assembly | GO:0030240 | 2 | 0.034 | Human |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.034 | |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.034 | Human |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.034 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.034 | |
| protein catabolic process | GO:0030163 | 221 | 0.034 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.034 | |
| defense response to bacterium | GO:0042742 | 119 | 0.033 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.033 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.033 | |
| regulation of calcium transporting atpase activity | GO:1901894 | 2 | 0.033 | |
| cell adhesion | GO:0007155 | 329 | 0.033 | |
| harderian gland development | GO:0070384 | 2 | 0.033 | |
| germ cell development | GO:0007281 | 185 | 0.033 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.033 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.033 | |
| regulation of potassium ion transmembrane transporter activity | GO:1901016 | 7 | 0.033 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.032 | |
| muscle fiber development | GO:0048747 | 76 | 0.032 | Human |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.032 | |
| ossification | GO:0001503 | 216 | 0.032 | |
| sarcomere organization | GO:0045214 | 24 | 0.031 | Human |
| adult locomotory behavior | GO:0008344 | 91 | 0.031 | |
| tube closure | GO:0060606 | 91 | 0.031 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.031 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.031 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.031 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.031 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.031 | |
| response to starvation | GO:0042594 | 65 | 0.031 | |
| gas homeostasis | GO:0033483 | 3 | 0.031 | |
| response to inactivity | GO:0014854 | 4 | 0.031 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.031 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.031 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.031 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.030 | |
| positive regulation of blood circulation | GO:1903524 | 22 | 0.030 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.030 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.030 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.030 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.030 | |
| positive regulation of atpase activity | GO:0032781 | 3 | 0.030 | |
| regulation of lipid storage | GO:0010883 | 20 | 0.030 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.030 | |
| adaptive immune response | GO:0002250 | 155 | 0.030 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.030 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.030 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.030 | |
| gpi anchor biosynthetic process | GO:0006506 | 6 | 0.030 | |
| calcium ion dependent exocytosis of neurotransmitter | GO:0048791 | 7 | 0.029 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.029 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.029 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.029 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.029 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.029 | |
| regulation of calcium ion transmembrane transporter activity | GO:1901019 | 20 | 0.029 | |
| rna interference | GO:0016246 | 2 | 0.029 | |
| hormone secretion | GO:0046879 | 128 | 0.029 | |
| positive regulation of ion transmembrane transporter activity | GO:0032414 | 15 | 0.029 | |
| mapk cascade | GO:0000165 | 281 | 0.029 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.028 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.028 | Human |
| nephric duct formation | GO:0072179 | 4 | 0.028 | |
| lipid modification | GO:0030258 | 65 | 0.028 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.028 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.028 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.028 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.028 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.028 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.027 | |
| cell cell signaling involved in lung development | GO:0060495 | 1 | 0.027 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.027 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.027 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.027 | |
| adult behavior | GO:0030534 | 135 | 0.027 | |
| male sex differentiation | GO:0046661 | 109 | 0.027 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.027 | |
| regulation of cell growth | GO:0001558 | 91 | 0.027 | |
| regulation of atpase activity | GO:0043462 | 9 | 0.026 | |
| lipid transport | GO:0006869 | 98 | 0.026 | |
| response to steroid hormone | GO:0048545 | 56 | 0.026 | |
| defense response to other organism | GO:0098542 | 197 | 0.026 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.026 | |
| tube formation | GO:0035148 | 140 | 0.026 | |
| negative regulation of axon extension | GO:0030517 | 19 | 0.026 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.026 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.026 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.026 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.026 | |
| stem cell differentiation | GO:0048863 | 268 | 0.025 | |
| semicircular canal fusion | GO:0060879 | 1 | 0.025 | |
| regulation of ossification | GO:0030278 | 112 | 0.025 | |
| gpi anchor metabolic process | GO:0006505 | 7 | 0.025 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.025 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.025 | |
| regulation of heart rate | GO:0002027 | 36 | 0.025 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.025 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.025 | |
| regulation of white fat cell proliferation | GO:0070350 | 2 | 0.025 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.025 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.025 | |
| vasoconstriction | GO:0042310 | 27 | 0.025 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.024 | |
| regulation of microtubule cytoskeleton organization | GO:0070507 | 37 | 0.024 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.024 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.024 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.024 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.024 | |
| positive regulation of transmembrane transport | GO:0034764 | 29 | 0.024 | |
| cellular response to lipid | GO:0071396 | 145 | 0.024 | |
| response to muscle stretch | GO:0035994 | 1 | 0.024 | Human |
| carboxylic acid transport | GO:0046942 | 100 | 0.024 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.024 | |
| regulation of protein transport | GO:0051223 | 163 | 0.024 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.024 | |
| positive regulation of sequestering of triglyceride | GO:0010890 | 4 | 0.024 | |
| regulation of secretion | GO:0051046 | 274 | 0.023 | |
| translation | GO:0006412 | 93 | 0.023 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.023 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.023 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.023 | |
| regulation of protein localization | GO:0032880 | 231 | 0.023 | |
| dna metabolic process | GO:0006259 | 303 | 0.023 | |
| gtp catabolic process | GO:0006184 | 143 | 0.023 | |
| semicircular canal formation | GO:0060876 | 1 | 0.023 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.023 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.023 | |
| l glutamate import into cell | GO:1990123 | 3 | 0.022 | |
| angiogenesis | GO:0001525 | 201 | 0.022 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.022 | |
| myoblast differentiation | GO:0045445 | 52 | 0.022 | |
| t cell proliferation | GO:0042098 | 120 | 0.022 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.022 | |
| regulation of calcium ion transmembrane transport | GO:1903169 | 20 | 0.022 | |
| neural tube closure | GO:0001843 | 90 | 0.022 | |
| hindbrain development | GO:0030902 | 128 | 0.022 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.022 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.022 | |
| positive regulation of mitochondrial calcium ion concentration | GO:0051561 | 3 | 0.022 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.022 | |
| mammary gland bud formation | GO:0060615 | 2 | 0.022 | |
| dorsal ventral axon guidance | GO:0033563 | 3 | 0.022 | |
| chemotaxis | GO:0006935 | 247 | 0.022 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.021 | |
| epinephrine transport | GO:0048241 | 1 | 0.021 | |
| t cell differentiation involved in immune response | GO:0002292 | 30 | 0.021 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.021 | |
| extraocular skeletal muscle development | GO:0002074 | 2 | 0.021 | |
| regulation of relaxation of muscle | GO:1901077 | 8 | 0.021 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.021 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.021 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.021 | |
| response to oxidative stress | GO:0006979 | 123 | 0.021 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.021 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.021 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.021 | |
| tissue remodeling | GO:0048771 | 102 | 0.021 | |
| inflammatory response | GO:0006954 | 244 | 0.021 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.021 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.021 | |
| heart growth | GO:0060419 | 45 | 0.021 | |
